Status:
COMPLETED
RAE (Realize, Analyze, Engage)
Lead Sponsor:
ContinueYou, LLC
Collaborating Sponsors:
University of Massachusetts, Worcester
University of Texas at Tyler
Conditions:
Substance Use Disorders
Treatment Adherence and Compliance
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The proposed study will evaluate the detection of digital biomarkers of stress, and drug craving in a population of individuals undergoing treatment for substance use disorder
Detailed Description
RAE integrates digital detection of high-risk stress and craving periods by utilizing a mobile phone application and integrated wearable sensor. These detections are paired with interventions (mindful...
Eligibility Criteria
Inclusion
- 18 years or older
- Enrolled in an outpatient SUD treatment program
- Enrolled in treatment for \< 90 days
- Fluent in English
- Have access to a smartphone with iOS or Android Capabilities
- Capable of providing informed consent
Exclusion
- Pregnancy
- Prisoner Status
- Significant limitation of range of motion of non-dominant arm (amputation or fracture)
Key Trial Info
Start Date :
February 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2024
Estimated Enrollment :
209 Patients enrolled
Trial Details
Trial ID
NCT05227339
Start Date
February 22 2022
End Date
April 1 2024
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Massachusetts Chan Medical School
Worcester, Massachusetts, United States, 01655